Thus far, most studies have addressed the identification of H19 gene SNPs in bladder cancer 26, hepatocellular cancer 27, and lung cancer 28, whereas few studies focused on the role of H19 gene SNPs in neuroblastoma risk. This evidence concerns the gene H19 and hepatocellular carcinoma.